p.70 抽出テキスト

American College of Cardiology. Circulation 2014; 130: 1303-1334. PMID: 25223981 45. Drezner JA, Sharma S, Baggish A, et al. International criteria for electrocardiographic interpretation in athletes: Consensus statement. Br J Sports Med 2017; 51: 704-731. PMID: 28258178 46. Corrado D, Pelliccia A, Bjørnstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26: 516-524. PMID: 15689345 47. Corrado D, Pelliccia A, Heidbuchel H, et al. Section of Sports Cardiology, European Association of Cardiovascular Prevention and Rehabilitation. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 2010; 31: 243-259. PMID: 19933514 48. Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardiographic interpretation in athletes: the 'Seattle criteria'. Br J Sports Med 2013; 47: 122-124. PMID: 23303758 49. Sheikh N, Papadakis M, Ghani S, et al. Comparison of electrocardiographic criteria for the detection of cardiac abnormalities in elite black and white athletes. Circulation 2014; 129: 1637-1649. PMID: 24619464 50. Dhutia H, Malhotra A, Finocchiaro G, et al. Diagnostic yield and financial implications of a nationwide electrocardiographic screening programme to detect cardiac disease in the young. Europace 2021; 23: 1295-1301. PMID: 33570096 51. Williams EA, Pelto HF, Toresdahl BG, et al. Performance of the American Heart Association (AHA) 14-Point Evaluation Versus Electrocardiography for the Cardiovascular Screening of High School Athletes: A Prospective Study. J Am Heart Assoc 2019; 8: e012235. PMID: 31286819 52. Sarto P, Zorzi A, Merlo L, et al. Value of screening for the risk of sudden cardiac death in young competitive athletes. Eur Heart J 2023; 44: 1084-1092. PMID: 36760222 53. 文部科学省.児童生徒等の健康診断情報の利活用について(令和元年5月28日).https://www5.cao.go.jp/keizai-shimon/kaigi/special/ reform/committee/20190528/shiryou2.pdf 54. 三谷義英.成育基本法と脳卒中・循環器病対策基本法:その要点と小児診療へのかかわり.小児科 2023;64:51-57. 55. 内閣府.経済財政運営と改革の基本方針2022.https://www5.cao. go.jp/keizai-shimon/kaigi/cabinet/honebuto/2022/decision0607.html 56. 厚生労働省.医療DX について:医療DX の概要.https://www. mhlw.go.jp/stf/iryoudx.html#1 57. デジタル庁.自治体・医療機関等をつなぐ情報連携システム

(Public Medical Hub:PMH).https://www.digital.go.jp/policies/ health/public-medical-hub 58. 日本小児循環器学会,日本循環器学会.学校心臓検診のデジタル化に関する提言.https://jspccs.jp/wp-content/uploads/n241118-2. pdf 59. 文部科学省.GIGA スクール構想の実現について.https://www. mext.go.jp/a_menu/other/index_00001.htm 60. 日本循環器学会,日本不整脈心電学会.不整脈非薬物治療ガイドライン(2018年改訂版).https://www.j-circ.or.jp/cms/wp-content/ uploads/2018/07/JCS2018_kurita_nogami.pdf 61. Silvetti MS, Colonna D, Gabbarini F, et al. New Guidelines of Pediatric Cardiac Implantable Electronic Devices: What Is Changing in Clinical Practice? J Cardiovasc Dev Dis 2024; 11: 99. PMID: 38667717 62. Silvetti MS, Bruyndonckx L, Maltret A, et al. The SIDECAR project: S-IcD registry in European paediatriC and young Adult patients with congenital heaRt defects. Europace 2023; 25: 460-468. PMID: 36107451 63. Mori H, Sumitomo N, Tsutsui K, et al. Efficacy of SubcutAneous implantable cardioVErter-defibrillators in ≤18 year-old CHILDREN: SAVE-CHILDREN registry. Int J Cardiol 2023; 371: 204-210. PMID: 36087632 64. Jarman JW, Lascelles K, Wong T, et al. Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J 2012; 33: 1351-1359. PMID: 22408031 65. Pettit SJ, McLean A, Colquhoun I, et al. Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers. Pacing Clin Electrophysiol 2013; 36: 1532- 1538. PMID: 24033753 66. Griksaitis MJ, Rosengarten JA, Gnanapragasam JP, et al. Implantable

cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation. Eu- ropace 2013; 15: 523-530. PMID: 23333943 67. Silvetti MS, Pazzano V, Verticelli L, et al. Subcutaneous implantable

cardioverter-defibrillator: is it ready for use in children and young adults? A single-centre study. Europace 2018; 20: 1966-1973. PMID: 29939256 68. Ferreiro-Marzal A, Rodríguez-Serrano F, Esteban-Molina M, et al. Intermuscular S-ICD Implantation in Pediatric Patients. Thorac Cardiovasc Surg 2020; 68: 68-71. PMID: 31630382 69. Cortez D, Erickson K, Hiremath G, et al. Pediatric SubQ-ICD implantation, a single center review of the inter-muscular technique. Indian Pacing Electrophysiol J 2021; 21: 25-28. PMID: 33221529 70. Sarubbi B, Colonna D, Correra A, et al. Subcutaneous implantable cardioverter defibrillator in children and adolescents: results from the S-ICD "Monaldi care" registry. J Interv Card Electrophysiol 2022; 63: 283-293. PMID: 33709295 71. Wieniawski P, Buczyński M, Grabowski M, et al. Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience. Int J Environ Res Public Health 2022; 19: 11661. PMID: 36141934 72. von Alvensleben JC, White C, Brateng C, et al. Subcutaneous implantable cardioverter defibrillator placement in a 5-year-old patient: Modifications for the smallest patients. HeartRhythm Case Rep 2019; 5: 440-444. PMID: 31453099 73. Bordachar P, Marquié C, Pospiech T, et al. Subcutaneous implantable cardioverter defibrillators in children, young adults and patients with congenital heart disease. Int J Cardiol 2016; 203: 251-258. PMID: 26519678 74. Römers H, van Dijk V, Boersma L. Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias. Heart Rhythm O2 2023; 4: 59-64. PMID: 36713037 75. Thompson AE, Atwater B, Boersma L, et al. The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device-based treatment of sudden cardiac arrest. J Cardiovasc Electrophysiol 2022; 33: 1085-1095. PMID: 35478368 76. Baumgartner H, De Backer J, Babu-Narayan SV, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021; 42: 563-645. PMID: 32860028 77. Hammond BH, Etheridge SP, Saarel EV. Tetralogy of Fallot: A Long Journey but Getting Closer to Perfection. Circ Arrhythm Electrophysiol 2023; 16: e012042. PMID: 37339178 78. Krieger EV, Zeppenfeld K, DeWitt ES, et al. American Heart Association Adults With Congenital Heart Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young and Council on Clinical Cardiology. Arrhythmias in Repaired Tetralogy of Fallot: A Scientific Statement From the American Heart Association. Circ Arrhythm Electrophysiol 2022; 15: e000084. PMID: 36263773 79. Khairy P, Aboulhosn J, Gurvitz MZ, et al. Alliance for Adult Research in Congenital Cardiology (AARCC). Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation 2010; 122: 868-875. PMID: 20713900 80. Silka MJ, Hardy BG, Menashe VD, et al. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998; 32: 245- 251. PMID: 9669277 81. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000; 356: 975-981. PMID: 11041398 82. Habib E, Srivasthan K, El Masry H. Evaluation and Management of Sudden Death Risk in Repaired Tetralogy of Fallot. J Pers Med 2023; 13: 1715. PMID: 38138942 83. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022; 43: 3997-4126. PMID: 36017572 84. Kapel GF, Reichlin T, Wijnmaalen AP, et al. Re-entry using anatomically determined isthmuses: A curable ventricular tachycardia in repaired congenital heart disease. Circ Arrhythm Electrophysiol 2015; 8: 102-109. PMID: 25422392 85. van Zyl M, Kapa S, Padmanabhan D, et al. Mechanism and outcomes of catheter ablation for ventricular tachycardia in adults with repaired congenital heart disease. Heart Rhythm 2016; 13: 1449-1454. PMID: 26961296 86. Zeppenfeld K, Schalij MJ, Bartelings MM, et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation 2007; 116: 2241-2252. PMID: 17967973 87. Kapel GF, Sacher F, Dekkers OM, et al. Arrhythmogenic anatomical

isthmuses identified by electroanatomical mapping are the substrate